These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15358105)

  • 41. Molecular defects in erythropoietic protoporphyria with terminal liver failure.
    Schneider-Yin X; Schäfer BW; Möhr P; Burg G; Minder EI
    Hum Genet; 1994 Jun; 93(6):711-3. PubMed ID: 8005600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria.
    Schneider-Yin X; Gouya L; Dorsey M; Rüfenacht U; Deybach JC; Ferreira GC
    Blood; 2000 Aug; 96(4):1545-9. PubMed ID: 10942404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
    Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
    Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythropoietic protoporphyria.
    Lecha M; Puy H; Deybach JC
    Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review.
    Long ZB; Wang YW; Yang C; Liu G; Du YL; Nie GJ; Chang YZ; Han B
    J Zhejiang Univ Sci B; 2016 Oct.; 17(10):813-820. PubMed ID: 27704751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population.
    Colombo FP; Rossetti MV; Méndez M; Martínez JE; Enríquez de Salamanca R; del C Batlle AM; Parera VE
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):754-62. PubMed ID: 22591014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias.
    Gouya L; Puy H; Robreau AM; Lyoumi S; Lamoril J; Da Silva V; Grandchamp B; Deybach JC
    Hum Genet; 2004 Feb; 114(3):256-62. PubMed ID: 14669009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria.
    Parera VE; Koole RH; Minderman G; Edixhoven A; Rossetti MV; Batlle A; de Rooij FW
    Mol Med; 2009; 15(11-12):425-31. PubMed ID: 19693296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variations in the length of poly-C and poly-T tracts in intron 3 of the human ferrochelatase gene.
    Barman J; Schneider-Yin X; Mamet R; Schoenfeld N; Minder EI
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):102-10. PubMed ID: 19656458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ferrochelatase gene mutation in Singapore and a novel frame-shift mutation in an Asian boy with erythropoietic protoporphyria.
    Alagappan U; Pramono ZA; Chong WS
    Int J Dermatol; 2017 Mar; 56(3):272-276. PubMed ID: 28054335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
    Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
    Barman-Aksözen J; Béguin C; Dogar AM; Schneider-Yin X; Minder EI
    Blood Cells Mol Dis; 2013 Oct; 51(3):151-61. PubMed ID: 23787363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.
    Ohgari Y; Sawamoto M; Yamamoto M; Kohno H; Taketani S
    Hum Mol Genet; 2005 Jan; 14(2):327-34. PubMed ID: 15574461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria.
    Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
    J Invest Dermatol; 2007 Dec; 127(12):2790-4. PubMed ID: 17597821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular genetics of erythropoietic protoporphyria.
    Todd DJ
    Photodermatol Photoimmunol Photomed; 1998 Apr; 14(2):70-3. PubMed ID: 9638728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria.
    Li C; Di Pierro E; Brancaleoni V; Cappellini MD; Steensma DP
    Clin Chem Lab Med; 2009; 47(1):44-6. PubMed ID: 19055472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haplotype analysis in determination of the heredity of erythropoietic protoporphyria among Swiss families.
    Schneider-Yin X; Rüfenacht UB; Hergersberg M; Schnyder C; Deybach JC; Minder EI
    J Invest Dermatol; 2001 Dec; 117(6):1521-5. PubMed ID: 11886517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recessive inheritance of erythropoietic protoporphyria with liver failure.
    Schneider-Yin X; Taketani S; Schäfer B; Minder EI
    Lancet; 1994 Jul; 344(8918):337. PubMed ID: 7914284
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
    Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
    JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.
    Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.